For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Gensia Pharmaceuticals, Inc.

USPTO Granted Patents = 14

Forward Citations = 995

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Harry E Gruber (7 out of 47 patents)

Clinton E Browne (6 out of 12 patents)

Ronald R Tuttle (5 out of 22 patents)

4. Paul J Marangos (3 out of 15 patents)

5. Robert S Hillman (2 out of 22 patents)

6. Jack W Reich (2 out of 2 patents)

7. Walter John Bochenko (1 out of 39 patents)

8. Charles J McPhee (1 out of 39 patents)

9. Bheemarao G Ugarkar (1 out of 17 patents)

10. Paul K Laikind (1 out of 11 patents)

11. Ernest K Metzner (1 out of 6 patents)

12. John M Pawelchak (1 out of 2 patents)

13. Bheemaro G Vgarkar (1 out of 1 patent)

14. Leonard P Miller (1 out of 3 patents)

15. Kevin M Mullane (1 out of 5 patents)

14 patents: Sort by Forward Citations

1. 5817640 - Methods of preventing tissue damage associated with decreased blood flow (1998-10-06),

2. 5733259 - Method and apparatus for closed loop drug delivery (1998-03-31),

3. 5658889 - Method and compounds for aica riboside delivery and for lowering blood (1997-08-19),

4. 5395970 - 1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol (1995-03-07),

5. 5286252 - Diagnosis, evaluation and treatment of coronary artery disease by (1994-02-15),

6. 5236908 - Methods of treating injury to the central nervous system (1993-08-17),

7. 5234404 - Diagnosis, evaluation and treatment of coronary artery disease by (1993-08-10),

8. 5200525 - Anti-seizure compounds (1993-04-06),

9. 5187162 - Methods of treating neurodegenerative conditions (1993-02-16),

10. 5169388 - Pressure-activated medication dispenser (1992-12-08),

11. 5132291 - Antivirals and methods for increasing the antiviral activity of AZT (1992-07-21),

12. 5108363 - Diagnosis, evaluation and treatment of coronary artery disease by (1992-04-28),

13. 5088978 - Apparatus and method for iontophoretic transfer (1992-02-18),

14. 5082829 - AICA riboside prodrugs (1992-01-21),

Gensia Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative medicines to improve the lives of patients. With a focus on research and development, Gensia is committed to advancing treatments for a variety of medical conditions. Their team of experts work tirelessly to bring cutting-edge therapies to market, with a primary goal of making a positive impact on global healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#369 in San Diego, CA

#5,156 in California

#21,638 in US

#40,936 in the World

San Diego, CA, United States of America

Gensia Pharmaceuticals, Inc.

Forward Citations = 995

16 inventors:

Harry E Gruber (7 out of 47 patents)

Clinton E Browne (6 out of 12 patents)

Ronald R Tuttle (5 out of 22 patents)

4. Paul J Marangos (3 out of 15 patents)

5. Robert S Hillman (2 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…